BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37271963)

  • 1. Prevalence, risk factors and prognostic value of anxiety and depression in recurrent glioma patients.
    Liu X; Zhan G
    Psychol Health Med; 2023; 28(9):2474-2485. PubMed ID: 37271963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiety and depression in glioma patients: prevalence, risk factors, and their correlation with survival.
    Hao A; Huang J; Xu X
    Ir J Med Sci; 2021 Aug; 190(3):1155-1164. PubMed ID: 33140294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiety and depression during 3-year follow-up period in postoperative gastrointestinal cancer patients: prevalence, vertical change, risk factors, and prognostic value.
    Li J; Ma C
    Ir J Med Sci; 2023 Dec; 192(6):2621-2629. PubMed ID: 36862310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiety and depression in recurrent gastric cancer: Their prevalence and independent risk factors analyses.
    Zhang L
    Medicine (Baltimore); 2021 Dec; 100(51):e28358. PubMed ID: 34941152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-scale assessment of anxiety and depression in postoperative non-small cell lung cancer patients: their prevalence, risk factors, and prognostic potency.
    Deng L; Chen B
    Ir J Med Sci; 2023 Dec; 192(6):2613-2619. PubMed ID: 36826710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors, prognostic potency, and longitudinal variation of anxiety and depression in postoperative glioma patients.
    Wu X; Wang D; Wang D
    Front Surg; 2022; 9():1069709. PubMed ID: 36726957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation of Anxiety and Depression During a 3-Year Period as Well as Their Risk Factors and Prognostic Value in Postoperative Bladder Cancer Patients.
    Guo M; Li Y; Wang W; Kang X; Chen G
    Front Surg; 2022; 9():893249. PubMed ID: 35928029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, risk factors, and prognostic value of anxiety and depression in acute myeloid leukemia.
    Zhong T; Xu D; Li W
    Acta Haematol; 2024 Feb; ():. PubMed ID: 38342094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence, risk factors, and prognostic value of anxiety and depression in refractory or relapsed acute myeloid leukemia patients of North China.
    Gu M; Hao X; Cong L; Sun J
    Medicine (Baltimore); 2019 Dec; 98(50):e18196. PubMed ID: 31852076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and correlation of anxiety and depression on the prognosis of postoperative non-small-cell lung cancer patients in North China.
    Huang X; Zhang TZ; Li GH; Liu L; Xu GQ
    Medicine (Baltimore); 2020 Mar; 99(11):e19087. PubMed ID: 32176035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiety and depression prevalence and their risk factors in lupus nephritis patients: A case-control study.
    Hu Y; Zhan G
    Immun Inflamm Dis; 2022 Sep; 10(9):e689. PubMed ID: 36039650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personality traits, patient-centered health status and prognosis of brain tumor patients.
    Bunevicius A
    J Neurooncol; 2018 May; 137(3):593-600. PubMed ID: 29327173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The longitudinal changes of anxiety and depression, their related risk factors and prognostic value in colorectal cancer survivors: a 36-month follow-up study.
    Zhou L; Sun H
    Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101511. PubMed ID: 33713979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-traumatic stress disorders in patients with low-grade glioma and its association with survival.
    Jiang C; Wang J
    J Neurooncol; 2019 Apr; 142(2):385-392. PubMed ID: 30706175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults.
    Silverberg JI; Gelfand JM; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Ong PY; Chiesa Fuxench ZC; Simpson EL
    Br J Dermatol; 2019 Sep; 181(3):554-565. PubMed ID: 30838645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, risk factors and prognostic value of anxiety and depression in cervical cancer patients underwent surgery.
    Zhao H; Zhao Z; Chen C
    Transl Cancer Res; 2020 Jan; 9(1):65-74. PubMed ID: 35117159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaints.
    van der Meer PB; Koekkoek JAF; van den Bent MJ; Dirven L; Taphoorn MJB
    J Neurooncol; 2021 May; 153(1):89-98. PubMed ID: 33822293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, risk factors and prognostic role of anxiety and depression in surgical gastric cancer patients.
    Han L
    Transl Cancer Res; 2020 Mar; 9(3):1371-1383. PubMed ID: 35117485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 5-year follow-up assessment of anxiety and depression in postoperative prostate cancer patients: longitudinal progression and prognostic value.
    Li X; Zhang Y; Wang Y
    Psychol Health Med; 2023 Feb; 28(2):529-539. PubMed ID: 36050900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiety faintly and depression remarkably correlate with recurrence in acute ischemic stroke patients: A study with 3-year longitude evaluation and follow-up.
    Luan S; Wu X; Yin S
    Medicine (Baltimore); 2022 Jan; 101(3):e28521. PubMed ID: 35060506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.